Illumina Inc
ILMN94.660USD
-8.050-7.84%
收盤 08/01, 16:00（美東）報價延遲15分鐘
15.05B總市值
虧損本益比TTM
關於 Illumina Inc 公司
Illumina, Inc. 致力於提供基於測序和陣列的遺傳和基因組分析解決方案。其產品和服務服務於各個市場的客戶，使基因組解決方案能夠在研究和臨牀環境中得到採用。其 DNA 測序技術基於可逆終止子測序化學，稱爲合成測序生物化學。其 BeadArray 技術在製造過程中結合了微型珠子和基質，以生產可同時執行多項檢測的陣列。其測序應用包括全基因組測序試劑盒（可對任何大小和複雜程度的整個基因組進行測序）和靶向重測序試劑盒（可對外顯子組、特定基因、RNA 或其他感興趣的基因組區域進行測序）。其客戶包括基因組研究中心、學術機構、政府實驗室、醫院、製藥、生物技術、商業分子診斷實驗室等。
公司簡介
公司代碼ILMN
公司名稱Illumina Inc
上市日期Jun 28, 2000
成立日期2000
CEOMr. Jacob Thaysen, Ph.D.
員工數量8970
證券類型Ordinary Share
年結日Jun 28
公司地址5200 Illumina Way
城市SAN DIEGO
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編92122
電話18582024500
網址https://www.illumina.com
公司代碼ILMN
上市日期Jun 28, 2000
成立日期2000
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Jacob Thaysen, Ph.D.
Mr. Jacob Thaysen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
24.94K
+98.06%
Dr. Robert S. (Rob) Epstein, M.D.
Dr. Robert S. (Rob) Epstein, M.D.
Independent Director
Independent Director
22.14K
+20.59%
Dr. Frances H. Arnold, Ph.D.
Dr. Frances H. Arnold, Ph.D.
Independent Director
Independent Director
21.03K
+21.92%
Mr. Philip W. (Phil) Schiller
Mr. Philip W. (Phil) Schiller
Independent Director
Independent Director
20.15K
+23.09%
Ms. Patricia (Pat) Leckman
Ms. Patricia (Pat) Leckman
Chief People Officer
Chief People Officer
19.25K
+60.86%
Mr. Scott Davies
Mr. Scott Davies
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
18.93K
+58.70%
Dr. Steven (Steve) Barnard, Ph.D.
Dr. Steven (Steve) Barnard, Ph.D.
Chief Technology Officer
Chief Technology Officer
17.13K
-31.74%
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Independent Director
Independent Director
16.43K
+29.88%
Ms. Caroline D. Dorsa
Ms. Caroline D. Dorsa
Independent Director
Independent Director
15.19K
+21.71%
Ms. Susan E. (Sue) Siegel
Ms. Susan E. (Sue) Siegel
Independent Director
Independent Director
14.46K
+35.38%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Jacob Thaysen, Ph.D.
Mr. Jacob Thaysen, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
24.94K
+98.06%
Dr. Robert S. (Rob) Epstein, M.D.
Dr. Robert S. (Rob) Epstein, M.D.
Independent Director
Independent Director
22.14K
+20.59%
Dr. Frances H. Arnold, Ph.D.
Dr. Frances H. Arnold, Ph.D.
Independent Director
Independent Director
21.03K
+21.92%
Mr. Philip W. (Phil) Schiller
Mr. Philip W. (Phil) Schiller
Independent Director
Independent Director
20.15K
+23.09%
Ms. Patricia (Pat) Leckman
Ms. Patricia (Pat) Leckman
Chief People Officer
Chief People Officer
19.25K
+60.86%
Mr. Scott Davies
Mr. Scott Davies
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
18.93K
+58.70%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Consumables
768.00M
73.78%
Services and Other revenue
161.00M
15.47%
Instruments
112.00M
10.76%
地區USD
名稱
營收
佔比
Americas
570.00M
54.76%
Europe
293.00M
28.15%
Asia, Middle East, and Africa
106.00M
10.18%
Greater China
72.00M
6.92%
業務
地區
業務USD
名稱
營收
佔比
Consumables
768.00M
73.78%
Services and Other revenue
161.00M
15.47%
Instruments
112.00M
10.76%
股東統計
更新時間: 14 小時前
更新時間: 14 小時前
持股股東
股東類型
持股股東
持股股東
佔比
Capital World Investors
11.94%
The Vanguard Group, Inc.
10.29%
BlackRock Institutional Trust Company, N.A.
8.85%
Capital Research Global Investors
4.17%
State Street Global Advisors (US)
3.70%
Other
61.04%
持股股東
持股股東
佔比
Capital World Investors
11.94%
The Vanguard Group, Inc.
10.29%
BlackRock Institutional Trust Company, N.A.
8.85%
Capital Research Global Investors
4.17%
State Street Global Advisors (US)
3.70%
Other
61.04%
股東類型
持股股東
佔比
Investment Advisor
55.86%
Investment Advisor/Hedge Fund
26.27%
Hedge Fund
10.41%
Pension Fund
2.98%
Research Firm
2.52%
Bank and Trust
1.81%
Sovereign Wealth Fund
1.19%
Individual Investor
0.18%
Insurance Company
0.09%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
1970
169.77M
107.25%
-17.38M
2025Q1
2072
170.79M
107.89%
-16.32M
2024Q4
2074
166.23M
104.94%
-15.71M
2024Q3
2038
151.41M
95.06%
-11.30M
2024Q2
2033
149.41M
93.80%
-18.06M
2024Q1
2096
153.02M
96.09%
-8.97M
2023Q4
2134
150.48M
94.76%
-5.28M
2023Q3
2162
152.18M
96.14%
-14.52M
2023Q2
2203
154.10M
97.47%
-5.40M
2023Q1
2219
149.37M
94.55%
-9.34M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Capital World Investors
18.90M
11.94%
+874.11K
+4.85%
Mar 31, 2025
The Vanguard Group, Inc.
16.30M
10.29%
+552.07K
+3.51%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
14.01M
8.85%
-14.57K
-0.10%
Mar 31, 2025
Capital Research Global Investors
8.64M
5.46%
+630.00
+0.01%
May 31, 2025
State Street Global Advisors (US)
5.85M
3.7%
+58.31K
+1.01%
Mar 31, 2025
WCM Investment Management
4.18M
2.64%
+49.16K
+1.19%
Mar 31, 2025
Loomis, Sayles & Company, L.P.
4.15M
2.62%
-62.95K
-1.50%
Mar 31, 2025
Corvex Management LP
3.83M
2.42%
+2.13M
+125.25%
Mar 31, 2025
Baillie Gifford & Co.
3.01M
1.9%
-7.40K
-0.25%
Mar 31, 2025
Brown Advisory
2.91M
1.84%
+996.59K
+52.11%
Mar 31, 2025
查看更多
持股ETF
更新時間: 10 小時前
更新時間: 10 小時前
機構名稱
佔比
Invesco Biotechnology & Genome ETF
5.63%
Global X Genomics & Biotechnology ETF
4.92%
First Trust Nasdaq Lux Digi Health Solutions ETF
4.18%
First Trust NYSE Arca Biotechnology Index Fund
4.01%
VanEck Biotech ETF
3.01%
ARK Genomic Revolution ETF
2.5%
First Trust NASDAQ Pharmaceuticals ETF
2.01%
ROBO Global Healthcare Technology & Innovation ETF
2%
Alger Russell Innovation ETF
1.96%
Abacus FCF Innovation Leaders ETF
1.86%
查看更多
Invesco Biotechnology & Genome ETF
佔比5.63%
Global X Genomics & Biotechnology ETF
佔比4.92%
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比4.18%
First Trust NYSE Arca Biotechnology Index Fund
佔比4.01%
VanEck Biotech ETF
佔比3.01%
ARK Genomic Revolution ETF
佔比2.5%
First Trust NASDAQ Pharmaceuticals ETF
佔比2.01%
ROBO Global Healthcare Technology & Innovation ETF
佔比2%
Alger Russell Innovation ETF
佔比1.96%
Abacus FCF Innovation Leaders ETF
佔比1.86%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
